Vincent Sandanayaka,Sharon Shechter,Sharon Shacham,Dilara McCauley,Erkan Baloglu
申请号：
US14747394
公开号：
US09861614B2
申请日:
2015.06.23
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to compounds of formula I:and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using the compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
